Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage

Journal of Controlled Release

Volumn 95, Issue 1, 2004, Pages 101-108

  Chambin, O ^a   Champion, D ^b   Debray, C ^a   Rochat Gonthier, M H ^a   Le Meste, M ^b   Pourcelot, Y ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Drug release; Ethyl cellulose; Hydroxypropylmethyl cellulose; Microcrystalline cellulose; Nuclear magnetic resonance

Indexed keywords

DISSOLUTION; DRUG PRODUCTS; HYDRATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

DRUG RELEASE;

CELLULOSE DERIVATIVES;

CELLULOSE DERIVATIVE; DRUG CARRIER; ETHYL CELLULOSE; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; THEOPHYLLINE;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; HYDRATION; MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFORMULATION; PRIORITY JOURNAL; TABLET FORMULATION;

EID: 0842330732     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.11.009     Document Type: Article

References (27)

1. Dressman J.B., Amidon G.L., Reppas C., Shad V.P. Dissolution testing as a pronostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15:1998;11-22.
2. Chen M.-L., Shad V., Patnaik R., Adams W., Hussain A., Conner D., Mehta M., Malinowski H., Lazor J., Huang S.-M., Hare D., Lesko L., Sporn D., Williams R. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm. Res. 18:2001;1645-1650.
3. Pillay V., Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release. 55:1998;45-55.
4. Katzhendler I., Mäder K., Friedman M. Correlation between drug release kinetics from proteineous matrix and matrix structure: EPR and NMR study. J. Pharm. Sci. 89:2000;365-381.
5. Yoshioka S., Aso Y., Kojima S. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature. Pharm. Res. 16:1999;135-140.
6. A.H. Kibbe, Handbook of Pharmaceutical Excipients, Third ed., The Pharmaceutical Press, London and American Pharmaceutical Association, Washington, 2000.
7. Lustig-Gustafsson C., Johal H.K., Podczeck F., Newton J.M. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation. Eur. J. Pharm. Sci. 8:1999;147-152.
8. Chambin O., Bérard V., Rochat-Gonthier M.H., Pourcelot Y. Dry adsorbed emulsion: 2. Dissolution behaviour of an intricate formulation. Int. J. Pharm. 235:2002;169-178.
9. Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13:2001;123-133.
10. Katzhendler I., Mäder K., Azoury R., Friedman M. Investigating the structure and properties of hydrated hydroxypropyl methylcellulose and egg albumin matrices containing carbamazepine: EPR and NMR study. Pharm. Res. 17:2000;1299-1308.
11. 2H NMR mobility in cellulose. Carbohydr. Polym. 46:2001;49-57.
12. 1H-NMR. J. Phys. Chem. 102:1998;10483-10489.
13. Phadnis N.V., Suryanarayanan R. Polymorphism in anhydrous theophylline - implications on the dissolution rate of theophylline tablets. J. Pharm. Sci. 86:1997;1256-1263.
14. Ticehurst M.D., Storey R.A., Watt C. Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug. Int. J. Pharm. 247:2002;1-10.
15. Sabnis S., Adeyeye C.M. Controlled-release hydrophilic tablets for individualized theophylline therapy. Drug Dev. Ind. Pharm. 25:1998;187-196.
16. Khan G.M., Zhu J.-B. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J. Control. Release. 57:1999;197-203.
17. Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization. Pharm. Res. 14:1997;804-809.
18. Colombo P., Bettini R., Peppas N.A. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug. J. Control. Release. 61:1999;83-91.
19. Nokhodchi A., Ford J.L., Rubinstein M.H. Studies on the interaction between water and (hydroxypropyl)methylcellulose. J. Pharm. Sci. 86:1997;608-615.
20. Siepmann J., Podual K., Sriwongjanya M., Peppas N.A., Bodmeier R. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J. Pharm. Sci. 88:1999;65-72.
21. Rekhi G.S., Jambhekar S.S. Ethylcellulose - a polymer review. Drug Dev. Ind. Pharm. 21:1995;61-77.
22. Barra J., Falson-Rieg F., Doelker E. Modified drug release from inert matrix tablets prepared from formulations of identical composition but different organisations. J. Control. Release. 65:2000;419-428.
23. Kulvanich P., Leesawat P., Patomchaiviwat V. Release characteristics of the matrices prepared from co-spray-dried powders of theophylline and ethylcellulose. Drug Dev. Ind. Pharm. 28:2002;727-739.
24. Neau S.H., Howard M.A., Claudius J.S., Howard D.R. The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets. Int. J. Pharm. 179:1999;97-105.
25. Kothari S.J., Kumar V., Banker G.S. Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline celluloses, and powdered celluloses. Int. J. Pharm. 232:2002;69-80.
26. Fyfe C.A., Blazek A.I. Investigation of hydrogel formation from hydroxypropylmethylcellulose (HPMC) by NMR spectroscopy and NMR imaging techniques. Macromolecules. 30:1997;6230-6237.
27. Byrn S.R., Xu W., Newman A.W. Chemical reactivity in solid-state pharmaceuticals: formulation implications. Adv. Drug Deliv. Rev. 48:2001;115-136.